<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
  <mods>
    <titleInfo>
      <title>The role of HLA-G in parasitic diseases</title>
    </titleInfo>
    <name type="personnal">
      <namePart type="family">Sabbagh</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Sonon</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Sadissou</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Mendes</namePart>
      <namePart type="given">C. T.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Garcia</namePart>
      <namePart type="given">André</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Donadi</namePart>
      <namePart type="given">E. A.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Courtin</namePart>
      <namePart type="given">David</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <physicalDescription>
      <internetMediaType>text/pdf</internetMediaType>
      <digitalOrigin>born digital</digitalOrigin>
      <reformattingQuality>access</reformattingQuality>
    </physicalDescription>
    <abstract>Little attention has been devoted to the role of HLA-G gene and molecule on parasitic disorders, and the available studies have focused on malaria, African and American trypanosomiasis, leishmaniosis, toxoplasmosis and echinococcosis. After reporting a brief description regarding the role of the cells of innate and adaptive immune system against parasites, we reviewed the major features of the HLA-G gene and molecule and the role of HLA-G on the major cells of immune system. Increased levels of soluble HLA-G (sHLA-G) have been observed in patients presenting toxoplasmosis and in the active phase of echinococcosis. In addition, increased sHLA-G has also been associated with increased susceptibility to malaria and increased susceptibility to develop human African trypanosomiasis (HAT). In contrast, decreased membrane-bound HLA-G has been reported in placenta of patients infected with Plasmodium falciparum and in heart and colon of patients presenting Chagas disease. The 30 untranslated region of the HLA-G gene has been the main focus of studies on malaria, HAT and Chagas disease, exhibiting distinct patterns of associations. Considering that HLA-G is an immune checkpoint molecule, inhibiting the activity of several cells of the immune system, the excessive neoexpression and the increased sHLA-G levels together with the decreased constitutive tissue expression of membrane-bound HLA-G may be detrimental to the host infected with parasite agents.</abstract>
    <targetAudience authority="marctarget">specialized</targetAudience>
    <subject>
      <topic>echinococcosis</topic>
      <topic>genetics</topic>
      <topic>HLA-G</topic>
      <topic>immune system</topic>
      <topic>leishmaniosis</topic>
      <topic>malaria</topic>
      <topic>parasite</topic>
      <topic>toxoplasmosis</topic>
      <topic>trypanosomiasis</topic>
    </subject>
    <subject authority="local">
      <geographic>AFRIQUE SUBSAHARIENNE</geographic>
      <geographic>AMERIQUE LATINE</geographic>
    </subject>
    <classification authority="local">052</classification>
    <classification authority="local">050</classification>
    <relatedItem type="host">
      <titleInfo>
        <title>HLA</title>
      </titleInfo>
      <part>
        <detail type="volume">
          <number>91</number>
        </detail>
        <detail type="volume">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <list> 255-270</list>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2018</dateIssued>
      </originInfo>
      <identifier type="issn">2059-2302</identifier>
    </relatedItem>
    <identifier type="uri">https://www.documentation.ird.fr/hor/fdi:010072479</identifier>
    <identifier type="doi">10.1111/tan.13196</identifier>
    <identifier type="issn">2059-2302</identifier>
    <location>
      <shelfLocator>[F B010072479]</shelfLocator>
      <url usage="primary display" access="object in context">https://www.documentation.ird.fr/hor/fdi:010072479</url>
      <url access="row object">https://www.documentation.ird.fr/intranet/publi/2018/04/010072479.pdf</url>
    </location>
    <accessCondition type="restriction access" displayLabel="Accès réservé">Accès réservé (Intranet de l'IRD)</accessCondition>
    <recordInfo>
      <recordContentSource>IRD - Base Horizon / Pleins textes</recordContentSource>
      <recordCreationDate encoding="w3cdtf">2018-05-04</recordCreationDate>
      <recordChangeDate encoding="w3cdtf">2018-05-04</recordChangeDate>
      <recordIdentifier>fdi:010072479</recordIdentifier>
      <languageOfCataloging>
        <languageTerm authority="iso639-2b">fre</languageTerm>
      </languageOfCataloging>
    </recordInfo>
  </mods>
</modsCollection>
